Angion is a clinical-stage biopharmaceutical company developing small molecule therapeutics to address fibrotic diseases and acute organ injuries. Its lead program is ANG-3070. Angion was founded in 1998 and headquartered in Uniondale, NY.
Name / Ticker | Price | Zen Rating |
---|---|---|
$20.82 | A | |
$5.48 | A | |
$70.15 | A |